drugset
drugset / Trial / NCT01208155

Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets

NCT01208155 ↗

Phase 1 Completed 24 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

Study in healthy males to assess bioavailability of 4 different fostamatinib tablets

Timeline

Start
2010-09
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostamatinib Small molecule 100 mg Oral

Indications

No indication recorded.